Stamford, CT -- (SBWIRE) -- 01/31/2014 -- OTC Stock Picks is engaged in providing the most up to date and useful information on the Best Penny Stocks that are poised to breakout. Our penny stock newsletter alerts the market with picks that Wall Street stock traders have ignored or haven’t found out about yet. Here are some of the most awesome penny stocks we came up with that the ‘underground penny stock experts’ are always bragging about in their penny stock newsletters. Have a look on today’s market movers: Medbox Inc (OTCMKTS:MDBX), CEL-SCI Corporation (NYSEMKT:CVM), Keryx Biopharmaceuticals (NASDAQ:KERX), American Realty Capital Properties Inc (NASDAQ:ARCP)
Medbox Inc (OTCMKTS:MDBX) opened the session at $34.35, trading in a range of $34.10 - $37.43. The stock showed a positive performance of +10.45% in the last trading session from its previous close of $33.40 and closed at $36.89. The stock traded on a volume of 128,712 shares and the average volume of the stock remained 282,991 shares. Medbox Inc. (Medbox) offers a machine that dispenses medication to individuals based on biometric identification (fingerprint sample). The machine allows pharmacies, hospitals, doctors' offices, and alternative medicine clinics to manage employee possession of sensitive drugs.
For How Long MDBX will Fight for Profitability? Read This Trend Analysis report
CEL-SCI Corporation (NYSEMKT:CVM) traded 1.61 million shares in the last business day while the average volume of the stock remained 2.53 million shares. The stock showed a negative movement of -3.74% to end at $1.03. The 52 week range of the stock remained $0.53 - $3.09. CEL-SCI Corporation (CEL-SCI) is engaged in the business of Multikine cancer therapy; New cold fill manufacturing service to the pharmaceutical industry, and ligand epitope antigen presentation System (LEAPS) technology, with two products, hemagglutinin type 1 and neuraminidase type 1 (H1N1) swine flu treatment for H1N1 hospitalized patients and CEL-2000, a rheumatoid arthritis treatment vaccine.
Has CVM Found The Bottom And Ready To Gain Momentum? Find Out Here
Keryx Biopharmaceuticals (NASDAQ:KERX) reported 4.85 million shares were exchanged during the last trade, while the average volume is about 3.27 million shares. The stock escalated +2.80% and finished the day at $15.81. The beta of the stock is recorded at 3.92. Keryx Biopharmaceuticals, Inc. (Keryx) is a biopharmaceutical company focused on the acquisition, development and commercialization of pharmaceutical products for the treatment of cancer and renal disease.
For How Long KERX’s Gloss will Attract Investors? Find out via this report
American Realty Capital Properties Inc (NASDAQ:ARCP) shares rose, +0.14 percent from its previous close of $13.91 to close at $13.93. Traded with volume of 8.05 million shares in the prior session and the average volume of the stock remained 7.26 million shares. American Realty Capital Properties, Inc. is a real estate investment trust (REIT). The Company owns and acquires single-tenant, freestanding commercial real estate primarily subject to medium-term net leases with credit quality tenants. The Company is externally managed by ARC Properties Advisors, LLC. In February 2013, it announced the closing of the transaction to acquire American Realty Capital Trust III, Inc.
Why Should Investors Buy ARCP After The Recent Gain? Just Go Here and Find Out
About OTC Stock Picks
The team is among the US market leaders in connecting stocks to investors. With over two decades of market experience, the team prides itself on having the ‘pulse’ of the stock market. The company tracks over 100 different stocks with the goal of bringing investor attention to stock trading opportunities. The team is exceptional at predicting momentum-changes in stocks via technical analysis and fundamentals, and quickly relaying this information through its penny stock newsletter. The company offers investors Free Level II service and Free Real Time Stock Charts on its company website.
OTC Stock Picks is not a registered securities adviser. Investors should always conduct their own additional due diligence with any potential investment or highlighted company. The company provides updates on selected stocks via press releases, newsletters, and company website, but this should not be construed as a recommendation to buy or sell.
Read full disclaimer at: http://otcstockpicks.net/disclaimer/
Copyright © 2005-2014 - SBWire, The Small Business Newswire - All Rights Reserved - Important Disclaimer
Contact Us: 888-4-SBWIRE (US) - 920-593-5640 (International)